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Tendons represent a bradytrophic tissue which is poorly vascularized and, compared
to bone or skin, heal poorly. Usually, a vascularized connective scar tissue with inferior
functional properties forms at the injury site. Whether the increased vascularization is
the root cause of tissue impairments such as loss of collagen fiber orientation, ectopic
formation of bone, fat or cartilage, or is a consequence of these pathological changes
remains unclear. This review provides an overview of the role of tendon vasculature in
healthy and chronically diseased tendon tissue as well as its relevance for tendon repair.
Further, the nature and the role of perivascular tendon stem/progenitor cells residing in
the vascular niche will be discussed and compared to multipotent stromal cells in other
tissues.
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INTRODUCTION
Tendons are fibrous bands of connective tissue which connect muscle to bone and are able to
withstand tension. Besides the mere transmission of force, their physiologic role is also the storage
and recovery of energy, made possible by specific biomechanical properties. Upon damage, either
due to traumatic injury and/or chronic degeneration, the macromolecular structure is disturbed,
resulting in inferior tissue quality. Unlike in other, highly vascularized tissues such as skin or bone,
neovascularization following tendon injury is not necessarily a hallmark of functional tissue repair.
Instead, it is associated with degeneration as healthy tendons generally are poorly vascularized with
relatively few cells embedded in an abundant collagenmatrix. The aim of this review is to provide an
overview of our current understanding of tendon vasculature and its role in healthy and developing
tendon as well as the involvement of the vascular bed in tendon de- and regeneration.
VASCULATURE IN INTACT TENDONS
In early medical literature tendons are described as “virtually dead during life” (Edwards, 1946),
based on the fact that tendons are poorly vascularized and contain only few cells compared to other
tissues. Even though the vascular and lymphatic network had been visualized by dye injections,
tendons were considered to be “non-viable cables” (Peacock, 1959). Nevertheless, although tendons
resemble a sparsely vascularized tissue type they generally harbor more vessels than commonly
believed.
Mechanisms and Sources of Vascularization
Generally, blood vessels emanate into tendons from the musculo—tendineous junction, from
the bone insertion site, and the so called “paratenon,” a loose areolar gliding tissue surrounding
non-synovial tendons (Peacock, 1959; Schmidt-Rohlfing et al., 1992; Ahmed et al., 1998; Kannus,
2000). The complexity of the vascular network also depends on whether tendons are sheathed,
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that is embedded in synovial tissue, or is unsheathed. In 1953,
Brockis J.G. has shown that in the sheathed digital flexor tendons
of the palm vessels only enter the tendon at few distinct sites,
whereas in the distal part of the pals and in the forearm,
where the tendon is surrounded by paratenon tissue, vessels
pass through the tissue more frequently (Brockis, 1953). These
two “types” of tendon were later on referred to as “avascular
tendons” and “vascular tendons,” with major implications for the
understanding of adhesion formation following surgical repair
(see below; Chaplin, 1973). Nevertheless, even though tendons
clearly are not “non-viable cables,” they are poorly vascularized
and particularly the avascular superficial zones of sheathed
tendons are mainly nourished by diffusion from the synovial
sheath.
Generally, the number of supplying vascular branches
significantly differs between various tendons. For example, the
patellar ligament is supplied by a total of three arteries and by
the anastomotic arch from the Hoffa fat pad (Pang et al., 2009),
whereas the Achilles tendon is supplied both by the peroneal
and the posterior tibial arteries (Schmidt-Rohlfing et al., 1992).
As tendons naturally are moving tissues which are extended by
mechanical load, also the vasculature must be compliant to being
stretched. In vascular tendons, vessels form “curves” within their
embedding endotenon tissue, a loose areolar intratendineous
tissue surrounding individual fascicles (Kannus, 2000). Upon
loading of the tendon the vessels are stretched accordingly
(Brockis, 1953). An illustrative andwell described example for the
anatomy of tendon vascularization is the rotator cuff, a group of
four muscles and the connected tendons moving and stabilizing
the glenohumeral joint. Despite the fact that all four tendons
serve a relatively similar function, the supraspinatus tendon is
unique in terms of its vascular bed. In this tendon initially an
avascular zone, referred to as the “critical zone,” usually located
about 1 cm proximal from the bony insertion has been described
(Lindblom, 1939). However, subsequent studies demonstrated
the presence of a vascular bed and it was postulated that the filling
of the blood vessels was dependent on the positioning of the arm
(Rathbun and MacNab, 1970). Such relative avascular zones have
also been described for other tendons, i.e., the Achilles tendon
(Stein et al., 2000) or the patella tendon (Clancy et al., 1981).
Clinically these zones, also referred to as the “watershed area” in
the Achilles tendon, are often prone to inflammatory episodes,
potentially resulting in a painful and chronic tendinopathy (Józsa
and Kannus, 1997) and/or rupture of the tendon (Alfredson et al.,
2001).
The role of the vasculature during tendon development and
maturation is also still poorly defined. Peacock (1959) describes
embryonic tendons to be “supplied with a rich capillary network,”
by analysing images of an 8 month old human embryo. A study
in postnatal, immature sheep describes a massive decline in both
cellularity and vessel density in the tendon of the extrinsic flexor
muscles of the fingers (musculus flexor digitorum superficialis)
(Meller et al., 2009). In line with these findings, several studies
point out the (relative) decrease of cell density during tendon
maturation (Ippolito et al., 1980; Józsa and Kannus, 1997;
Oryan and Shoushtari, 2008). Given the fact that very little
turnover of the extracellular matrix occurs in human tendons
after termination of linear growth after (∼ 17–18 years of age),
low vascular supply seems appropriate (Heinemeier et al., 2013).
For example, the half–life of collagen in mature equine tendons
was calculated to be about 200 years (Thorpe et al., 2010).
The maintenance of hypo- or avascularity certainly requires
either the production of antiangiogenic factors or the inhibition
of proangiogenic factors. Indeed both mechanisms have
been described in e.g., the hypovascular zones of sheathed
tendons (Pufe et al., 2005). The proangiogenic protein vascular
endothelial growth factor (VEGF) is found to be highly expressed
in cells from fetal and injured human tendons, however only
low expression is evident in intact adult tendons (Pufe et al.,
2001) (Figure 1A). The antiangiogenic factor endostatin, a
proteolytic fragment of Collagen XVIII, is also involved in
tendon vascularization. The distribution of endostatin in gliding
tendons correlates with the grade of vascularization. Endostatin
expression is strong in the gliding area and reduced in areas
without pressure and the expression levels are described to be
influenced by mechanical load (Pufe et al., 2003) (Figure 1B).
Taken together, our understanding of the molecular machinery
controlling the complex vascularization process in tendons
however remains fragmentary.
Lymphatic Drainage of Tendons
So far, the lymphatic drainage of intact tendons has gained very
little attention. Early literature reports lymphatic vessels to be
associated with blood vessels in calf tendons as demonstrated
by injection of India ink (Edwards, 1946). However, by now it
is commonly accepted that the identification of lymph vessels
simply by morphologic parameters is insufficient and even by
means of immunohistochemistry it is challenging to separate
blood from lymph vessels. A minimum of three lymph associated
markers is recommended to distinguish lymph from blood
vessels (Schroedl et al., 2014). Lymphatics play a crucial role
in tissue repair mechanisms, due to injury or inflammatory
processes and it has long been known that lymph vessels
proliferate during inflammation. However, the role of lymphatic
vessels in tendon disease has been neglected so far. To our
knowledge there is no literature available on the lymphatic
drainage in common tendon disorders such as tendinopathy,
calcific tendinitis, or chronic tendon inflammation due to
mechanic overuse. Recently, we have shown that intact rat
Achilles tendons are void of lymphatics, which start to grow
into the tendon repair tissue upon injury (Tempfer et al., 2015).
Whether lymphatic ingrowth is a cause for impaired tissue
quality and scar formation or merely a side effect requires further
investigation. This may pave the way for future attempts to
target lymphatic vessels to improve tendon regeneration, as it is
successfully performed in other, non-musculoskeletal diseases,
such as corneal and ocular surface inflammation (Bock et al.,
2013).
Tendon Vessels as a Niche for Stem/
Progenitor Cells
As with many other tissues, vertebrate tendons harbor a
population of stem/ progenitor cells (Salingcarnboriboon et al.,
2003; Bi et al., 2007; Tempfer et al., 2009). These cells display
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FIGURE 1 | Embryonic tendons show a high density of tendon cells producing VEGF, ultimately resulting in a pronounced angiogenic response in
developing tendons (A). In healthy adult tendons the relative cell density decreases and tenocytes produce the antiangiogenic factor endostatin in response to
physiological mechanical load, thus limiting neo-angiogenesis (B). In diseased tendons, tenocytes produce HIF-1 in response to mechanical overload and/ or hypoxia.
HIF-1 in turn induces the expression of VEGF, promoting neoangiogenesis. Hemorrhage due to vascular injury also leads to an increase in VEGF and to the production
of matrix metalloproteinases (MMPs), resulting in a further weakening and degradation of the tendon matrix (C).
mesenchymal stem cell (MSC)—like properties, displaying plastic
adherence and a differentiation potential toward the osteoblast,
adipocyte, and chondrocyte lineage. Further, they express
classical MSC—associated surface markers such as Stro-1, CD44,
CD90, and CD146 (Salingcarnboriboon et al., 2003; Bi et al., 2007;
Rui et al., 2013) and reside within a fibromodulin- and biglycan-
rich niche (Bi et al., 2007). We have shown that perivascular
cells of the human supraspinatus tendon harbor a population of
cells expressing both tendon- and stem cell associated markers
(Tempfer et al., 2009). This is well in line with the finding
that perivascular cells derived from a variety of tissues, such
as skeletal muscle, pancreas, adipose tissue, and placenta show
MSC–properties (Crisan et al., 2008). Interestingly, Mienaltowski
et al. (2013) describe the presence of two distinct stem/progenitor
cell populations within tendons, either located in the paratenon
or the tendon proper. Both cell sources were negative for the
perivascular surface marker CD133 and a differential expression
pattern for the vascular marker endomucin as well as for
tenomodulin and scleraxis. These data suggest that different
stem/progenitor cell populations exist within distinct niches at
the tendon proper and peritenon and the stem/progenitor cells
in the peritenon might be more vascular in origin.
Generally, the role of perivascular MSCs in regeneration
remains a matter of debate. Caplan A.I. proposes these cells to
be activated upon local injury and to act as immunomodulatory
agents guiding inflammation and regeneration (Caplan, 2008).
Particularly in tendon, the function of resident stem/ progenitor
cells remains unclear. As tendons naturally only have a
poor regenerative capacity, leading to inferior tissue quality
following injury or chronic degeneration, the pool of endogenous
stem/progenitor cells apparently fails to functionally restore the
damaged tissue within the milieu of an injured tendon (Voleti
et al., 2012). Actually, tendon stem/progenitor cells are suspected
to contribute to tendon degeneration by differentiation toward
the osteoblast/chondrocyte lineage (Magne and Bougault, 2015).
In diseases such as calcific tendinitis or in the formation of
bony enthesophytes in spondyloarthritis, ectopic bone is formed
within tendons. As tendon stem/progenitor cells have an even
higher potential to undergo osteogenic differentiation than bone
marrow derived MSC (Bi et al., 2007), it is speculated that they
at least contribute to the pathogenesis of calcific tendinitis (Rui
et al., 2011). Taken together, the in vivo role of tendon stem
cells remains largely unknown and they potentially contribute to
both tendon homeostasis and tendon pathologies by direct cell
differentiation and/or production of trophic factors.
Nevertheless, transplantation of bone-marrow stromal cells
and tendon-derived stem/progenitor cells has been proven to be
beneficial for the functional repair of tendon tissue in various
animal models (reviewed by Docheva et al., 2015). Recently, Lee
CH et al. have shown that a rare tendon resident population
of perivascular cells expressing CD146 can be expanded and
stimulated in vivo by connective tissue growth factor (CTGF)
in order to regenerate a tendon defect in a rat model (Lee
et al., 2015). However, in order to fully harness the regenerative
capacity of tendon stem cells we need to gain further insight into
the in vivo identity of these cells and how they are modulated by
the local niche. So far, this remains experimentally challenging
due to the lack of tendon-specific markers.
VASCULATURE IN TENDON DISEASE
Tendon Adhesion Formation
Peritendinous adhesions often lead to significant functional
impairment after tendon surgery. Particularly sheathed tendons,
such as the flexor tendon of the hand, frequently lose their
gliding capacity after surgical repair, with a prevalence of ∼ 4%
being reported (Dy et al., 2012). In a rabbit study, three
main factors have been identified, which in combination
support the formation of adhesions: (i) suture of the partially
damaged tendon, (ii) excision of the synovial sheath, and (iii)
immobilization. If only one of these factors is avoided, adhesion
formation can be significantly reduced (Matthews and Richards,
1976).
As nutrition of sheathed tendons is mainly provided by
diffusion from the synovial membrane, the local loss of this
tissue combined with a fibrin clot on the avascular outer layer
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of the tendon causes invasion of microvessels resulting in
the formation of fibrous adhesions (Pennington, 1979). More
recently, tendon adhesion formation using a mouse model
for flexor tendon injury has been demonstrated to follow a
typical wound healing response, with overlapping phases of
inflammation, vessel ingrowth, and an increase in apoptotic cells
over a follow-up time-period of 120 days (Wong et al., 2009).
Attempts to block adhesion formation by merely “wrapping”
the tendon with organic or inorganic materials failed as the
tendon proper became necrotic in many cases, indicating the
importance of vascular supply (Weckesser and Shaw, 1949;
Chaplin, 1973). Current research-based strategies include the
use of multilayer membranes loaded with non-steroidal anti-
inflammatory drugs (NSAIDs) to prevent fibrosis, mimicking the
synovial membrane (Jiang et al., 2015) as well as the implantation
of bioengineered synovia—like membranes (Baymurat et al.,
2015).
Vasculature in Achilles Tendinopathy
Tendinopathy is a painful, chronic disease commonly affecting
various tendons such as the Achilles tendon or the tendons of the
lateral elbow (“Tennis elbow”). As Achilles tendinopathy (AT) is
the most frequent and best studied form of this disease, we will
focus on this particular tendon. AT often affects people with high
levels of sports activities. For example, 52% of elite long-distance
runners are at risk for sustaining an Achilles tendon injury during
their career (Kujala et al., 2014). AT is characterized by pain
in the tendon during initial loading, subsiding with continued
activity; as the condition becomes chronic, pain can be persistent.
Overuse is considered to be the underlying cause; however
the etiology and pathogenesis have not yet been fully clarified.
Similarly, the source of the pain and the underlying mechanisms
of pain remain unclear. Histologically, matrix disruption is
commonly observed in AT, but is not necessarily involved in the
pathogenesis as it also occurs in asymptomatic tendons (Magnan
et al., 2014). Neovascularization is commonly seen in AT, as
shown by Doppler sonography (Ohberg et al., 2001; Zanetti et al.,
2003) and along with the ingrowth of vessels, also innervation is
enhanced in tendinopathic zones, which may be causative for the
pain associated with AT (Alfredson et al., 2001).
As mentioned above, during tendon development, high levels
of VEGF are expressed. Molecules that are developmentally
regulated are often re-expressed during the disease state. Indeed,
the expression of VEGF in degenerative and spontaneously
ruptured Achilles tendons is detectable at high concentrations
when compared with adult, healthy Achilles tendons (Pufe et al.,
2001). In vitro, cyclic mechanical load induces the expression of
VEGF and hypoxia inducible factor 1 (HIF-1) in a frequency
dependent fashion, indicating this mechanism being involved
in tendon cell response to overload (Petersen et al., 2006)
(Figure 1C).
Some authors report AT to be a result of an inadequate repair
process following microtrauma, i.e., due to overuse. Because
of the lack of blood vessels within the mid portion of the
tendon a neurogenic inflammatory process is activated to repair
these microruptures. This neurogenic inflammation occurs in the
tissue surrounding the Achilles tendon and matrix and induces
the expression of metalloproteinases (MMPs) responsible for the
degradation of extracellular matrix. Concomitantly, cytokines
such as VEGF, epidermal growth factor (EGF), and platelet-
derived growth factor (PDGF) are overexpressed. VEGF not only
promotes angiogenesis, but also upregulates the expression of
MMPs and downregulates tissue inhibitors of metalloproteinases
(TIMP-3), further progressing the remodeling of the tendon
tissue (van Sterkenburg and van Dijk, 2011).
Tendon stem/ progenitor cells are also suspected to
contribute to the pathophysiology of tendinopathies. In a rabbit
tendinopathy model it was shown that tendon stem/ progenitor
cells display an altered cell fate in vitro. They proliferate less and
have a greater potential do undergo osteogenic and chondrogenic
differentiation (Rui et al., 2011). Indeed, mineralization processes
are also found in human AT and patella tendinopathy. One study
on human tendinopathic tissue demonstrated that some
mineralized deposits in Achilles and patella tendons are
formed by a process resembling endochondral ossification, with
bone formation and remodeling mediated by populations of
osteoblasts and osteoclasts (Fenwick et al., 2002).
Regarding treatment strategies for AT, eccentric loading (e.g.,
muscle movements leading to muscle and tendon elongation)
has shown to be a safe, cheap, and effective method to
reduce pain and to improve tendon structure (Beyer et al.,
2015). Interestingly, this method also reduces the number of
neovessels in the affected area, which is considered to be
causative for the beneficial outcome (Ohberg and Alfredson,
2004). Similarly, a combination of cryotherapy and compression
of the tendinopathic area was shown to be an effective treatment,
leading to a significant reduction of tendon blood flow (Knobloch
et al., 2006). Also the use of topical nitroglycerin and low
level laser irradiation are discussed to exert their positive
effects by affecting tendon microcirculation. Nitroglycerin is a
vasodilator and the positive effects reported are likely due to
improved clearance of metabolic products, whereas low level
laser irradiation may cause microthrombosis and/ or partial
destruction of neovessels. However, for both therapies the
underlying mechanisms of action remain poorly understood
(Knobloch, 2008).
Another area often affected is the adult enthesis organ
that connects tendons with bone, allowing the transmission of
force from muscle to bone. The Achilles enthesis is frequently
affected by non-inflammatory enthesopathies due to overuse
or microtraumas and inflammation may occur resulting in
major pain and disability. However, the underlying intrinsic and
extrinsic factors also remain poorly understood.
Generally, mineralized and non-mineralized entheses can be
differentiated. The Achilles tendon enthesis organ is mineralized
and four zones can be distinguished: Zone 1 is built of
dense fibrous connective tissue (the tendon proper), and the
extracellular matrix (ECM) is mainly composed of collagen type
I and III. Zone 2 consists of non-mineralized fibrocartilage and
fibrochondrocytes. Here the ECM is formed by aggrecan and
the collagen types I, II, and III. Zone 3 is formed of mineralized
fibrocartilage with fibrochondrocytes, the predominant collagen
being Col II next to I and X as well as calcium phosphate crystals.
Between Zone 2 and Zone 3 the so called tidemark forms the
boundary between soft, non-mineralized, and hard, mineralized
tissue. Zone 4 finally is made up of the bone itself (Benjamin
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and McGonagle, 2009; Apostolakos et al., 2014). This gradual
transition from compliant soft tissue to rigid bone absorbs local
stress concentrations minimizing the risk of injury. Further, it
has been reported that there is no direct cellular communication
between bone and tendon tissue and the fibrocartilage at the
enthesis acts as a barrier between cells in the two tissues
(Ralphs et al., 1998).Whereas osteocytes and tendon cells directly
communicate via gap junctions, the fibrochondrocytes in the
calcified fibrocartilage zone were shown to lack similar structures.
Other than tendon, in a healthy state the enthesis is avascular
(Dörfl, 1969). The lack of blood vessels reflects the compressive
forces to which fibrocartilage is subject: vessel lumina would
be occluded by compression. However, intratendinous vessels
can anastomose directly with those of the bone at fibrous
entheses (Benjamin and McGonagle, 2001). Similar to tendon,
in development the enthesis is vascularized. During the growing
period, bone grows into the tendon by endochondral ossification,
where fibrocartilage is replaced by bone. Generally, cartilage
erosion must be preceded by vascular invasion, yet it remains
unclear how the blood vessels in the fibrous zone regress as
the fibrous tissue is replaced by fibrocartilage (Gao et al., 1996;
Benjamin and McGonagle, 2001).
CONCLUSIONS
Neovascularization is critical to tissue repair and wound healing.
Therefore, strategies to enhance vascularization to promote
regeneration are considered promising treatment modalities,
i.e., the use of platelet rich plasma (PRP) to restore functional
bone (Zhang et al., 2013) or skin (Kakudo et al., 2011).
However, in acute or chronic tendon injuries hypervascularity
often does not pave the way to functional recovery of the
tissue. Therefore, to overcome the limited intrinsic regeneration
capacity of tendon and to achieve scarless healing will most
likely require a balancedmanipulation of the angiogenic response
in tendon tissue. For a variety of treatment methods, such
as the use of PRP, the availability of clinical data is limited,
due to heterogeneity in application (Khan and Bedi, 2015). In
order to develop rational strategies to achieve a well-balanced
angiogenic response following tendon injury, we need a thorough
understanding of the molecular and cellular networks driving
tendon vascularization and regeneration—a challenge for years
to come.
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